Recent developments in cancer care continue to present hope for patients. Investigators are actively exploring innovative approaches, including harnessing the immune system, targeted agents, and personalized medicine . A key study published this week demonstrates the potential of a emerging drug in treating late-stage NSCLC. Furthermore, current tr